Authorities “Organization of’Expert Advisory Group’ for in-depth evaluation of thrombosis”
“The 2nd quarter vaccination plan proceeds without disruption…do not review plan change”
(Paris AFP = Yonhap News) The European Medicines Agency (EMA) reported on the 18th (local time) that a blood clot was formed in some who received a novel coronavirus infection (Corona 19) vaccine by a multinational pharmaceutical company AstraZeneca (AZ). The vaccine’s benefits outweigh the risk of side effects, he said. “It’s a safe and effective vaccine,” said EMA Commissioner Emma Cook at a press conference. The photo shows the AZ Corona 19 vaccine and syringe. [email protected]
(Seoul = Yonhap News) Reporter Shin Shin = The quarantine authorities reported on 20 cases in Korea where a brain blood clot was found after receiving AstraZeneca’s novel coronavirus infection (Corona 19) vaccine on the 20th. It was revealed that it corresponds to the’precautions’ for vaccination.
At a regular online briefing on this day, Park Young-jun, head of the adverse reaction investigation support team, said, “The result of the MRI (magnetic resonance imaging) test was confirmed as a cerebral vein thrombosis.” sinus thrombosis·CVST) can be suspected,” he explained.
Team leader Park said, “We are currently testing the causative factor,” and said, “We will evaluate the relevance (with vaccination) through the examination of the provincial rapid response team (if the results are available), and then the damage investigation team.”
CVST is a disease that causes brain insufficiency due to the formation of blood clots in the cerebral veins.
The European Medicines Agency (EMA) has said that the disease is very rare after vaccination with AstraZeneca, and further analysis is needed, as the association with vaccination cannot be completely ruled out.
Among the cases mentioned by EMA is disseminated intravascular coagulation (DIC).
After receiving the vaccination, CVST, DIC, etc., appeared mainly in women under the age of 55.
A patient in their 20s in Korea, who is a Corona 19 response agent, developed headache and chills for two days from the 10th of the last vaccination, and the situation continued to worsen from the 14th to the 15th, and the result of treatment confirmed thrombosis.
EMA advised medical professionals to seek medical attention immediately if signs of such ailments, such as severe headaches three days after vaccination, appear.
Jo Eun-hee, head of the post vaccination management team of the promotion group, said, “Today, through the Vaccination Specialized Committee, we plan to create and distribute information to medical staff.”
“We plan to organize and operate an expert advisory group to conduct an in-depth evaluation regarding abnormal immune reactions, especially thrombosis, which has been a problem recently.” .
Authorities said there are currently no plans to change the vaccination plan.
This is in response to the EMA’s tentative conclusion that the AstraZeneca vaccine was not associated with an increased overall risk of blood clots, evaluating the greater benefits of vaccination.
“The government is planning to proceed with vaccinations smoothly in accordance with the previously announced vaccination plan for the second quarter,” said Byeong-taek Bae, head of the situation general manager of the promotion group. “We are not currently reviewing changes to the existing vaccination plan.”
Bae said, “Today the Vaccination Specialist Committee will review the safety based on the domestic and overseas adverse reaction trends related to the AstraZeneca vaccine and the announcement of the EMA and discuss the focus of vaccination in the second quarter.”
(Seoul = Yonhap News) Reporter Shin Joon-hee = Medical staff are preparing for the vaccination at the inoculation center of the National Medical Center in Jongno-gu on the 20th, when the second vaccination of the Pfizer vaccine was conducted for workers in medical institutions that treat patients with Corona 19.
Pfizer vaccine should be given twice every three weeks (21 days), which is the third week after the first vaccination day, the 27th of last month. 2021.3.20 [email protected]
Meanwhile, in the case of Pfizer’s vaccine, the second vaccination began from this day.
The central vaccination center runs from this day to the 2nd of the following month, and the central vaccination center, Honam area, Yeongnam area center, and Daegu center take effect on the 24th to 30th.
In-house vaccination medical institutions receive refrigerated vaccines from the 29th to the 6th of the following month and give the second vaccination until the 10th of next month.
Unauthorized reproduction-prohibition of redistribution>
2021/03/20 16:22 sent